Text

Myasthenia Gravis: Current Review

---

Myasthenia gravis (MG) is an acquired autoimmune disorder characterized dinically by weakness of skeletal muscles and fatigability on exercise. Weakness increases during the day and improves with rest. Extraocular muscle (EOM) weakness or ptosis is present initially in 50% of patients and 90% accurs during the course of illness. AChE inhibitors and imunomodulating therapies are the mainstays of treatment. Inmild form. ACHE inhibitors are used. Important risk factors for poor prognosis include age older than 40 years, aprogressive diease, and thymoma.

---

Availability

No copy data

Detail Information

Series Title

-

Call Number

Cermin Dunia Kedokteran,36((6):413-416

Publisher

Jakarta : Kalbe Farma., 2009

Collation

3p.

Language

ISBN/ISSN

0125-913X

Classification

-

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

MYASTHENIA GRAVIS

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment